Ketamine cousin tested for gut relief in IBS patients
NCT ID NCT06788444
Summary
This study is testing whether a single low dose of esketamine (a medication related to ketamine) can help reduce symptoms of irritable bowel syndrome (IBS). Researchers are enrolling 552 adults with IBS who also have anxiety or depression and are scheduled for a colonoscopy. They'll measure changes in IBS symptoms, quality of life, and mental health over 6 weeks to see if this one-time treatment provides lasting relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100050, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.